Skip to main content
SellModerate Confidence
Investment thesis

Healthy revenue growth and constructive price momentum are supported by a defensible competitive position in healthcare apparel, but a forward P/E of 38.7x and a put/call ratio of 2.00 signal meaningful execution risk and limited room for disappointment.

Thesis pillars

  • Defensible Healthcare Apparel Moat→Stable
  • Expensive Forward Valuation→Stable
  • Growth Momentum Aligned↓Deteriorating
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 26, 2026

Full reasoning →

Open full analysis

FIGS, Inc. (FIGS) Stock Analysis

SellGrowthShortModerate Confidence

Consumer Cyclical · Apparel Manufacturing

Earnings in 7 days (2026-11-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Analyst target reached at $20.66 — A.R:R is negative (-1.3) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: core scrubwear styles.

FIGS sells premium healthcare scrubwear and apparel directly to approximately 2.9 million active customers through its DTC digital platform, mobile app, TEAMS B2B channel, and five Community Hub stores. Core scrubwear styles represented over 60% of net revenues in 2025. The... Read more

$20.66-19.5% A.UpsideScore 6.2/10#4 of 13 Apparel Manufacturing
QualityF-score9 / 9FCF yield2.29%
Stop $19.21Analyst target $16.64(reached)A.R:R -1.3:1
Analyst consensus$19.13-7.4%8 analysts
$20.66price
$19.13mean
$15
$22

Sell if holding. Analyst target reached at $20.66 — A.R:R is negative (-1.3) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: core scrubwear styles. Chart setup: No clear chart pattern; technical signals are mixed. Score 6.2/10, moderate confidence.

Passes 6/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 7d<=7d. Suitability: aggressive.

10-K grounded · weekly refresh

About FIGS, Inc.

About FIGS, Inc.

FIGS sells premium scrubwear and healthcare apparel to approximately 2.9 million active customers primarily through its direct-to-consumer digital platform — website and mobile app — plus a TEAMS B2B portal for institutional buyers and five Community Hub retail stores. The 17 core scrubwear styles in 10 core colors represented over 60% of net revenues in 2025. The company ships to customers across North America, Central America, South America, Europe, Asia, and the Middle East, with headquarters in Southern California and fulfillment operations in Goodyear, Arizona.

FIGS earns revenue through unit sales at primarily full price, supported by a shallow-buy, data-driven repurchase model that limits markdown exposure and maintained a product return rate near 10% from 2021 through 2025, far below the 30% to 40% return rates typical in online apparel. The TEAMS B2B platform serves hospitals, medical offices, and concierge clinics seeking standardized employee uniforms. The company markets through brand campaigns across email, digital, social media, and an ambassador program, plus paid-search and retargeting performance marketing. FIGS competes against wholesale-focused players Barco Uniforms, Landau Uniforms, and Superior Group of Companies, as well as digitally native peers Jaanuu, Mandala, and Fabletics. Most production utilizes the proprietary FIONx fabric technology sourced through diversified global third-party manufacturers.

Show full overview

The 10-K identifies co-founders Heather Hasson (Executive Chairman) and Trina Spear (CEO) as critical to business direction, with no key-man life insurance maintained on any senior management. If either founder were to depart, the company acknowledges this could make business management more difficult and impair net revenues. FIGS also faces potential competition from larger diversified apparel brands with established wholesale networks and substantially greater resources, any of which could apply pricing pressure that may impact margins if they expand into the premium healthcare apparel market.

See also: Consumer Cyclical · Apparel Manufacturing

From FIGS, Inc.'s most recent 10-K filing, extracted June 10, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29

Recent Developments — FIGS, Inc.

Generated 2026-10-29T11:53:51Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 5, 20267d to earnings· next earnings call

Thesis

Rewards
V7 quality resilience bonus: +0.2 (Q=7.3 in RISK_OFF)
Strong earnings beat streak (3/4)
High-quality business
Risks
Concentration risk — Product: core scrubwear styles
Analyst target reached - limited upside remaining
Near 52-week high (1.1% away)

Key Metrics

P/E (TTM)62.6
P/E (Fwd)54.0
Mkt Cap$3.4B
EV/EBITDA40.5
Profit Mgn8.7%
ROE14.8%
Rev Growth28.8%
Beta1.07
DividendNone
Rating analysts15

Quality Signals

Piotroski F9/9MoatWideCompounder✓

Options Flow

P/C1.50bearish
IV97%elevated

Concentration Risks(10-K Item 1A)

  • HIGHProductcore scrubwear styles
    10-K Item 1: 'The 17 core scrubwear styles that we produce year-round represented over 60% of our net revenues in 2025'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker·1 ceiling hit

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda
0.0
Pe
1.9
Forward Pe
2.1
Analyst Target
3.0
Peg Ratio
3.9
Ps
7.0
Forward P/E: 54.0xPEG: 2.70Expensive valuation
GatesA.R:R -1.3=NEGATIVEEARNINGS PROXIMITY 7d<=7dMomentum 5.8>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
87 · Overbought
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $13.20Resistance $20.88

Price Targets

A.Upside-19.5%
A.R:R-1.3:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (-19.5% upside)
! Negative risk/reward — downside exceeds upside
! EARNINGS_PROXIMITY:7d<=7d

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-05 (7d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is FIGS stock a buy right now?

Sell if holding. Analyst target reached at $20.66 — A.R:R is negative (-1.3) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: core scrubwear styles. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $19.21. Score 6.2/10, moderate confidence.

What is the FIGS stock price target?

Analyst target $16.64 reached (−19.5% from $20.66); no take-profit level is published. Prior stop was $19.21. Stop-loss: $19.21.

What are the risks of investing in FIGS?

Concentration risk — Product: core scrubwear styles; Analyst target reached - limited upside remaining; Near 52-week high (1.1% away).

Is FIGS overvalued or undervalued?

FIGS, Inc. trades at a P/E of 62.6 (forward 54.0). TrendMatrix value score: 3.0/10. Verdict: Sell.

What do analysts say about FIGS?

15 analysts cover FIGS with a consensus score of 3.9/5. Average price target: $19.

What does FIGS, Inc. do?FIGS sells premium healthcare scrubwear and apparel directly to approximately 2.9 million active customers through its...

FIGS sells premium healthcare scrubwear and apparel directly to approximately 2.9 million active customers through its DTC digital platform, mobile app, TEAMS B2B channel, and five Community Hub stores. Core scrubwear styles represented over 60% of net revenues in 2025. The company sources products from diversified global third-party manufacturers and competes against Barco Uniforms, Jaanuu, and Fabletics.

Related stocks: KTB (Kontoor Brands, Inc.) · GIL (Gildan Activewear, Inc.) · RL (Ralph Lauren Corporation) · GIII (G-III Apparel Group, LTD.) · LEVI (Levi Strauss & Co)
Home › Stocks › FIGS

Latest news

Latest News

StockStory197d ago
StockStory78d agoEarnings
StockStory176d agoEarnings
Yahoo Finance85d ago
Zacks Investment Research85d ago
StockStory85d agoEarnings
Investing.com Australia184d agoAnalyst
TipRanks184d ago
Nurse.org191d agoProduct
GuruFocus198d agoAnalyst
Yahoo Finance79d ago
Yahoo Finance79d ago
Yahoo Finance177d ago
Zacks Investment Research177d agoAnalyst
Moomoo182d agoAnalyst
MarketBeat182d agoEarnings
MSN182d ago
TipRanks196d ago
Yahoo Finance196d agoAnalyst
Yahoo Finance77d ago
Loading more...